• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptNIH Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
Biochim Biophys Acta. Author manuscript; available in PMC Dec 1, 2010.
Published in final edited form as:
PMCID: PMC2783689
NIHMSID: NIHMS149258

Role of Matrix Vesicles in Biomineralization

Summary

Matrix vesicles have been implicated in the mineralization of calcified cartilage, bone and dentin for more than 40 years. During this period, their exact role, if any in the nucleation of hydroxyapatite mineral, and its subsequent association with the collagen fibrils in the organic matrix has been debated and remains controversial. Several hypotheses have been recently introduced to explain in greater detail how matrix vesicles function in biomineralization. This review will summarize recent advances, and open questions in the ongoing saga of these interesting and enigmatic extracellular organelles.

Keywords: Matrix Vesicles, Calcification, Biomineralization, Alkaline Phosphatase, Hydroxyapatite, Nucleation

1. Introduction

The term matrix vesicles (MV) refers to small (20-200 nm) spherical bodies observed in the pre-mineralized matrix of dentin, cartilage and bone. They appear to be bounded by a lipid bilayer, and are often found associated with small crystals of calcium phosphate mineral. The purpose of this review is to summarize the properties of MV and to describe how they function in the process of mineralization. It should be emphasized that both the properties and the mechanism(s) through which MV function are active areas of investigation and in some contention. This summary is therefore a snapshot of current knowledge from one vantage point.

2. Matrix Vesicle Properties

MV were originally discovered through ultrastructural analysis of growth plate cartilage and in bone, where they were seen as the initial sites of mineral formation, prior to matrix mineralization [1-3]. Subsequent analysis revealed that they are derived from the plasma membrane of mineral forming cells (i.e. chondrocytes, osteoblasts, odontoblasts), but have a membrane composition different from the parent membrane [4-13]. In particular, MV are enriched in tissue non-specific alkaline phosphatase (TNAP), nucleotide pyrophosphatase phosphodiesterase (NPP1/PC-1), annexins (ANX; principally annexins II, V & VI) and phosphatidyl serine (PS) relative to the membranes from which they are derived (Table 1) [5,12,14-21]. MV also contain matrix metalloproteinases (MMPs) [22-24]. The acidic phospholipids can bind Ca2+, but more importantly, we have shown that they facilitate calcium dependent annexin binding, and are permissive for annexins to form calcium channels through the membrane [14,25,26]. Recently, proteomic analysis of MV isolated from cartilage and osteoblast cultures have confirmed and extended the list of MV protein constituents to include proteoglycan link proteins and actin, a variety of integrins and PHOSPHO-1, a recently discovered PE/PC phosphatase known to be expressed in hypertrophic cartilage and mineralizing osteoblasts and in MV (Boesze-Battaglia, Harrison and Golub, unpublished observations)[27-30].

Table 1
Principle Components of Matrix Vesicles

TNAP is the best studied of the MV proteins, and has been implicated in mineralization mechanisms since the 1920's [31]. A plethora of studies have confirmed the importance of TNAP in initiating mineral formation [32-34]. Mutations in TNAP which decrease its activity result in the genetic disease, hypophosphatasia, leading to undermineralization of bone; complete loss of TNAP activity is perinatal lethal. More recently, the role of NPP1 and pyrophosphate metabolism has come to the fore [35,36]. The occurrence of TNAP on the external surface of MV thus further emphasizes the centrality of these membranous particles in the calcification process [17]. Nonetheless, experiments carried out in our laboratories have shown that TNAP activity alone is not sufficient for normal mineralization, unless the enzyme is membrane anchored [37]. Thus, while regulation of extracellular PPi and Pi concentrations is clearly necessary for mineralization, TNAP appears to play additional roles in the process. By most accounts, MV constituents collaborate to initiate intravesicular mineral formation [38-42]. Some experts believe that these nanocrystals are released into the extravesicular space, where they are postulated to both seed additional crystals, and to mineralize collagen fibrils [39,40,42].

Work from our laboratories and others has demonstrated the importance of the membrane proteins known as annexins in MV function [14,26,39,43]. Annexins are Ca2+ and phospholipid binding proteins which, under the right conditions can form calcium channels through MV membranes [26]. These conditions include membranes with a high content of acidic phospholipids. We have demonstrated that MV contain annexins II, V and VI, and in such membranes, MV annexins can form a hexameric structure which appears to be associated with Ca2+ transport. Moreover, we have demonstrated that annexin V binds to Types II and X collagen [14]. MV also bind to collagens [14,44-46]. The best studied of these interactions is the binding of MV to the N-telopeptide of Type II collagen via MV associated annexin V [44,47]. In earlier work, Wu and coworkers provided evidence for MV binding to native, but not denatured Type I collagen via interaction with several MV proteins [46].

3. Role of MV Constituents in Mineralization

That MV play some role in the calcification of cartilage, bone and dentin is now generally accepted, although the exact nature and extent of that role remains controversial, and the mechanisms through which MV initiate matrix mineralization in these tissues remains unclear. An emerging consensus now emphasizes the central role of the MV enzymes TNAP and NPP1, in conjunction with the cell associated ankylosis protein (ANK) in regulating the onset of calcification [17,36,48,49]. The currently held doctrine posits that the activities of ANK and NPP1 function to suppress mineralization by increasing the extracellular concentration of the calcification inhibitor, pyrophosphate (PPi), while TNAP functions to promote mineralization by decreasing the concentration of PPi and increasing the concentration of the mineralization promoter, inorganic phosphate (Pi) (Table 2) [35,50-53]. In this scheme, extracellular PPi is formed from extracellular nucleoside triphosphates (NTP) by NPP1 and exported from cells through the action of ANK; it is hydrolyzed to Pi by TNAP.

Table 2
Matrix Pyrophosphate Effectors

Early studies of MV lipid composition determined that there were significant differences between the lipid content of MV and the plasma membranes from which they arise. Wuthier and colleagues cataloged these differences, and hypothesized that the increase in acidic phospholipids in MV was somehow associated with MV calcification [12,54,55]. Further studies from the Wuthier laboratory, along with those of Boyan and colleagues proposed that MV lipids could act as a nucleation site for hydroxyapatite formation [20,56,57]. This concept has been extensively developed under the concept of “nucleational core complex”, which describes the interactions of MV phospholipids, Ca2+, PO 3- and some M4V proteins to form a molecular architecture which nucleates apatite crystallization [58-62].

4. Martix Vesicle Biogenesis

Morphological evidence supports the view that MV arise from cells by a “budding” process. In contrast, one study carried out in hybrid osteosarcoma cells concluded, “that matrix vesicle biogenesis is independent and distinct from that of plasma membrane biogenesis.” [63]. This conclusion has not yet been generally accepted. Alternatively, the notion that MV arise from the plasma membrane is supported by comparative lipid and protein studies of the vesicle and the plasma membrane of the epiphyseal chondrocyte and osteoblasts. From these investigations, subtle structural differences in the composition of the two membranes suggest that MV originate from specific sites on the hypertrophic chondrocyte plasma membrane (PM). It has been shown that MV contain higher concentrations of acidic phospholipids (phosphatidylserine, PS and phosphatidylinositol, PI) than the chondrocyte PM [15]. Overall, chondrocyte membranes contain similar components to matrix vesicles, but in different proportions.

Recently we studied the lipid organization of MV and PM [64]. In this study, we determined that chick growth plate MV were highly enriched in membrane raft microdomains containing high levels of cholesterol, glycophosphatidylinositol GPI-anchored TNAP and phosphatidyl serine (PS) localized to the external leaflet of the bilayer. To determine how such membrane microdomains arise during chondrocyte maturation we explored the role of PM cholesterol-dependent lipid-assemblies, in regulating the activities of lipid translocators involved in the externalization of PS. We first isolated and determined the composition of detergent resistant membranes (DRMs) from chondrocyte PM. DRMs isolated from chondrocyte PM are enriched in Ganglioside I (GM1) and cholesterol as well as GPI-anchored TNAP. Furthermore, these membrane domains are enriched in PS (localized to the external leaflet of the bilayer) and had significantly higher TNAP activity than non-cholesterol enriched domains. To understand the role of cholesterol-dependent lipid assemblies in the externalization of PS we measured the activities of two lipid transporters involved in PS externalization, aminophospholipid translocase (APLT) and phospholipid scramblase (PLSCR1) during maturation of a murine chondrocytic cell line, N1511. In this study, we provided the first evidence that maturing chondrocytes express PLSCR1 and have scramblase activity.

In bone, MV are also thought to arise by budding from the osteoblast plasma membrane [39]. Fedde, while studying MV released by the human osteosarcoma cell line, Saos-2, concluded, “MVs originate from specialized regions of the PM and are released in the same orientation as the PM”[65]. In SaOSLM2 osteoblastic cells, Gillette and Nielsen-Preiss found that annexin 2 and TNAP were co-localized to lipid raft microdomains [66]. A very recent study using this cell line concluded that MV arise from microvilli seen at the apical plasma membrane [67]. This finding is reminiscent of much earlier studies reported by Ornoy and Hale [68,69]. At this time it is not clear how the specialized membrane domains observed in chondrocytes and the microvilli budding process are related.

5. Matrix Mineralization

The organic phase of bone, dentin, cementum and calcified cartilage is dominated by collagen fibrils, which serve as the scaffold for calcification. In addition to collagen, the pre-mineralized matrix contains proteoglycans and acidic non-collagenous proteins which are believed to assist and modulate collagen calcification. The principal non-collagenous proteins of bone can be classified as glycosaminoglycan-containing molecules, the proteoglycans, glycoproteins, and ã-carboxyglutamic acid-containing molecules, and phosphoproteins [42]. Of these, recent interest has focused on a subset of these proteins termed SIBLING's, an acronym for Small Integrin-Binding LIgand, N-linked Glycoprotein. The SIBLING's include osteopontin (OPN), bone sialoprotein (BSP), dentin matrix protein 1 (DMP1), dentin sialophosphoprotein (DSPP), enamelin and matrix extracellular phosphoglycoprotein (MEPE) [70]. Some of these proteins have been studied for their role in promoting or inhibiting mineralization in vivo and in vitro. DMP1, BSP and DSPP appear to promote mineralization, while OPN has been reported to exhibit both behaviors [71-79].

In calcifying cartilage, Type X collagen, fibronectin, matrix gla protein and transglutaminase 2 have been implicated in modulating mineralization [80-86]. Many studies have attempted to elucidate the role of matrix components in the mineralization process, and the structural basis for that role. Some generalizations have emerged: 1) many of the extracellular matrix protein are highly acidic, fueling speculation that they bind Ca2+, and are therefore postulated to either inhibit calcification or serve as nucleators; 2) many matrix proteins are highly phosphorylated, contributing to their acidity, providing phosphate-rich nucleation sites, and serving as putative substrates for matrix phosphatases (e.g. TNAP) and 3) some matrix proteins have well defined cell binding domains (e.g. RGD) [70,73,86-89]. The exact mechanisms through which these proteins modulate mineral formation is not yet clear, but there is little doubt that they play key roles in the process.

The endpoint for matrix mineralization is the deposition of small crystallites into collagen fibrils, probably at the hole zones in the collagen structure [90,91]. It has been shown that the classical Hodge-Petruska quarter staggered array of collagen molecules can be arranged so that the hole zones are aligned to form channels large enough to accommodate nanocrystals (see Figure 1) [92,93]. In early mineralization, apatite platelets become oriented so that their c-axes are parallel to the fiber axis; ultimately all of the intrafibrillar space is filled with mineral, resulting in a flexing of collagen molecules away from the fiber axis [90,94,95]. More recent observations using atomic force microscopy (AFM) have provided evidence consistent with these models. For example, Tong, et al have shown that the mineral in young bovine bone consists mainly of small apatite platelets (9×6×2 nm), which can be fit into aligned hole zones in the fibrillar structure as postulated by Katz and co- workers [93]. The conclusion from these studies is that small crystals can enter the fibril, probably via the hole zones and fibrillar pores, and that they further propagate within the fibril to fill all available space. The exact mechanism through which hydroxyapatite crystals form in vertebrate hard tissues has been widely debated [39,96-101]. The most likely mechanism proposed for bone and cartilage mineralization is based on the concept of heterogeneous nucleation [102]. This mechanism relies on organic or inorganic precursor seeds to direct the formation of apatite from soluble inorganic ions. Substantial differences exist among authorities as to where this nucleation occurs, and the exact molecular nature of the nucleator. One group of investigators propose that matrix vesicles are the site of initial or primary nucleation, as a prerequisite to subsequent secondary mineralization of the extracellular matrix [39,103-105]. An alternative view questions the feasibility of this approach on physical chemical grounds, and proposes, instead, direct nucleation of apatite by matrix macromolecules, principally collagen, but possibly also involving phosphoproteins, phospholipids and proteolipids [99,106-110]. Further, studies of the behavior of phosphoproteins in vitro is consistent with their role as nucleators or facilitators of nucleation [111,112]. Additional proteins thought to play key roles in the mineralization process include BAG-75, fetuin and DMP-1 [113-115]. While each of the major hypotheses for the initiation of mineralization is plausible and backed by a substantial body of evidence, none has been able to fully explain all of the known features of cartilage and bone calcification.

Figure 1
Cross sectional model of early collagen mineralization. The open circles represent triple helical collagen molecules and the large hatched circles represent mineral within the hole zone channels.

6. Role of MV in Mineral Nucleation

It is currently believed that MV have at least two principal roles in initiating calcification: 1) MV enzymes regulate the ratio of Pi to PPi in the extracellular fluid, and 2) MV proteins and lipids, including acidic phospholipids serve as nucleation sites for apatite deposition [39,42]. PPi, derived both from NPP1 catalyzed hydrolysis of extracellular NTP and from intracellular PPi transported via ANK, inhibits matrix mineralization, but not intravesicular mineral formation [116]. This inhibition is released through the action of TNAP, which hydrolyzes PPi, thus simultaneously removing the inhibitor and providing additional Pi for mineral formation (see Table 1) [35].

Thus, mineralization is said to proceed in two phases: an initial formation of apatite within MV, and a subsequent propagation phase in the matrix [35]. In this formulation, Ca2+ enters MV via an annexin channel and phosphate enters via a type III Na+ dependent phosphate transporter to form apatite within MV [117-119]. Acidic phospholipids and other MV components are thought to nucleate these intravesicular nanocrystals [25,39,42,120-122]. Subsequently, the intravesicular mineral seeds matrix macromolecules, principally collagens.

These proposed mechanisms are presented schematically in Figure 2. In panel A, The MV are depicted as solely involved in the regulation of matrix ion concentrations. The inhibitor PPi is hydrolyzed by TNAP, to form Pi. The Ca2+ and PO4 3- in the matrix can then initiate mineral formation at macromolecular nucleation sites as described above. In panel B, MV TNAP hydrolyzes PPi to Pi. Ca2+ and PO 3-4 ions enter MV and initiate mineral formation inside MV. As depicted in Figure 2 panel B, the crystals formed inside MV migrate to collagen, become inserted into the aligned hole zones of the fibrils, and then undergo maturation in the presence of extracellular Ca2+ and PO 3- 4 ions and the reduced PPi concentration. In panel C of Figure 2, all of the events depicted in panel B also are postulated to occur, but in addition, the physical interaction of MV with collagen fibrils facilitates the deposition of mineral into the fibrils. In this formulation, specific binding of MV to fibrils allows insertion of crystal into the fibrillar structure. In addition, MV associated MMPs may provide localized remodeling of the fibrils to expedite crystal entry (see below). Maturation is then expected to proceed as previously described. The latter hypothesis, depicted in panel C is being actively investigated in my laboratory.

Figure 2
Three possible mechanisms for the initiation of MV mediated matrix mineralization. In panel A, MV only regulate ion concentrations, leading to the formation of soluble molecular species which can initiate mineral formation in collagen fibrils. The circles ...

7. Matrix Metalloproteinases - Tissue Remodeling and Mineralization

Many reports have implicated MMPs in pathological mineralization associated with arthritis and cardiovascular calcification, but MMPs also appear to be important for normal tissue development and remodeling [123-131]. Moreover, MMPs have been localized to MV, where they may play significant roles in growth plate maturation and development [23]. In particular, matrix metalloproteases are expressed in growth plate cartilage, are associated with MV, and are required for the developmental processes which result in calcification of the growth plate, and its subsequent replacement by endochondral bone [24,132-135]. These data are consistent with recent work by Inada, et al. who reported on the effects of a null mutation in MMP-13 (collagenase-3) and concluded that this mutation resulted in abnormalities in growth plate development, including delayed ossification [125].

Tissue remodeling is a well known feature in development, which is closely associated with the expression of matrix degrading enzymes [136-140]. Tissue invasiveness by tumors also requires collagenolysis, and in cancer cells, enzymes which degrade collagen are often found associated with vesicles [141-143]. Mineralizing tissues also express matrix degrading enzymes which appear to be essential for the calcification process [144-146]. In addition to degrading collagen, gelatinases associated with MV can also degrade proteoglycans, which has been postulated to facilitate mineralization [147-150].

A number of MMPs are expressed in growth plate cartilage, including MMP-1, 2, 3 and 9, and the expression of these enzymes is regulated by 1,25-(OH)2-vitamin D, retinoic acid, TGFâ, and through integrin signaling [150-154]. Of particular interest is MMP-13, which is expressed in bone and cartilage, and appears to be under control of the transcriptional regulator, Cbfa1, the master regulator of bone formation [155]. Further, evidence is now accumulating that MMP's regulate growth factor economy in cartilage. For example, Boyan and Schwartz have recently shown that activation of MV MMP's by 1,25(OH)2D3 results in release of active growth factors from the cartilage matrix [156].

It has been known for many years that triple-helical collagen molecules are resistant to proteolysis by ordinary proteases, and instead that specific collagenases are required to degrade the molecules. Vertebrate collagenases specifically split Type I collagen between Gly775 and Ile776 in the alpha 1(I) chain and Gly775 and Leu776 in the alpha 2(I) chain, resulting in a larger fragment and a smaller fragment, the larger piece consisting of approximately 75% of the molecule and including the N-terminus [157,158]. MMP-13 can also release the N-terminal telopeptide of Type I collagen [158]. Collagenases cleave Type II collagen in a similar way between Gly975 & Leu976, in each of the 3 á-chains, although additional cleavages may also occur [159]. MMP-13 cleaves Type II collagen and also gelatin 40-fold more effectively than MMP-1. Once the initial cleavage by the collagenases is accomplished, the triple helical molecules denature at body temperature, and are susceptible to degradation by gelatinases, such as MMP-2 and 9, as well as other proteases.

8. Conclusions

Consideration of the data and hypotheses above leads to some distinct conclusions, and also leaves some open questions about the detailed role of MV in the mineralization of bone, cartilage and dentin. That they have some role(s) is now generally accepted. It is now understood that MV bud from the plasma membrane of mineral forming cells, but that they take with them a subset of the materials found in the parent membrane, leading to enrichment in the MV membrane of acidic phospholipids and certain proteins, particularly TNAP, NPP1 and Annexin V. In the case of TNAP, we estimate that the specific activity in cartilage MV is 10× higher than in the PM from chondrocytes (Harrison and Golub, unpublished). It is also clear that the three proteins, TNAP, NPP1 and Annexin V have important roles in the process, although one report suggests that annexin V is not required for skeletal development [160]. As MV also contain other annexins, it is possible the that function of annexin V is shared among several of them [161]. It is also clear that MV participate in regulating the concentration of PPi in the matrix. Removal of PPi promotes mineral formation. There are also big questions about the mechanism which have yet to be answered: 1) if the MV nucleational core complex is the site of apatite formation, how do the apatite crystal find their way to the collagen fibrils? 2) How does annexin binding to collagen modulate the mineralization process? 3) What role, if any, do MV MMP's play in the mechanism? 4) What is the function of the non-collagenous matrix proteins? These and many other details of the mechanism remain to be elucidated.

Acknowledgments

This work was supported in part by a Grant, DE017323-01, from the National Institute of Dental and Craniofacial Research

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Reference List

1. Anderson HC. Electron microscopic studies of induced cartilage development and calcification. J Cell Biol. 1967;35:81. [PMC free article] [PubMed]
2. Bonucci E. Fine structure of early cartilage calcification. J Ultrastruct Res. 1967;20:33. [PubMed]
3. Bernard GW, Pease DC. An electron microscopic study of initial intramembranous osteogenesis. American Journal of Anatomy. 1969;125:271. [PubMed]
4. Abad MJ, Nervina JM, Harrison G, Golub EE, Shapiro IM. An in-vitro system for isolating matrix vesicles from cultured bone cells. Journal of Dental Research. 1993;72:120.
5. Ali SY. Analysis of matrix vesicles and their role in the calcification of epiphyseal cartilage. Federation Proceedings. 1976;35:135. [PubMed]
6. Anderson HC. Molecular-biology of matrix vesicles. Clinical Orthopaedics and Related Research. 1995;314:266. [PubMed]
7. Glaser JH, Conrad HE. Formation of matrix vesicles by cultured chick embryo chondrocytes. Journal of Biological Chemistry. 1981;256:12607. [PubMed]
8. Golub EE, Schattschneider SC, Berthold P, Burke A, Shapiro IM. Induction of chondrocyte vesiculation in vitro. J Biol Chem. 1983;258:616. [PubMed]
9. Hayashi Y, Nagasawa H. Matrix vesicles isolated from apical pulp of rat incisors: crystal formation in low Ca × Pi ion-product medium containing beta-glycerophosphate. Calcified Tissue International. 1990;47:365. [PubMed]
10. Majeska RJ, Holwerda DL, Wuthier RE. Localization of phosphatidylserine in isolated chick epiphyseal cartilage matrix vesicles with trinitrobenzenesulfonate. Calcified Tissue International. 1979;27:41. [PubMed]
11. Shapiro IM, Burke A, Schattschneider S, Golub EE. Vesiculation of Chondrocytes. In: Asenzi A, editor. Proceedings of the Third International Conference on Matrix Vesicles; Milan: Wichtig Editore; 1981. pp. 33–39.
12. Wuthier RE. Lipids of matrix vesicles. Federation Proceedings. 1976;35:117. [PubMed]
13. Wuthier RE, Majeska RJ, Collins GM. Biosynthesis of matrix vesicles in epiphyseal cartilage. I. In vivo incorporation of 32P orthophosphate into phospholipids of chondrocyte, membrane, and matrix vesicle fractions. Calcified Tissue Research. 1977;23:135. [PubMed]
14. Kirsch T, Harrison G, Golub EE, Nah HD. The roles of annexins and types II and X collagen in matrix vesicle-mediated mineralization of growth plate cartilage. J Biol Chem. 2000;275:35577. [PubMed]
15. Majeska RJ, Wuthier RE. Studies on matrix vesicles isolated from chick epiphyseal cartilage. Association of pyrophosphatase and ATPase activities with alkaline phosphatase. Biochimica Et Biophysica Acta. 1975;391:51. [PubMed]
16. Hsu HH. Purification and partial characterization of ATP pyrophosphohydrolase from fetal bovine epiphyseal cartilage. Journal of Biological Chemistry. 1983;258:3463. [PubMed]
17. Siegel SA, Hummel CF, Carty RP. The role of nucleoside triphosphate pyrophosphohydrolase in in vitro nucleoside triphosphate-dependent matrix vesicle calcification. Journal of Biological Chemistry. 1983;258:8601. [PubMed]
18. Register TC, McLean FM, Low MG, Wuthier RE. Roles of alkaline phosphatase and labile internal mineral in matrix vesicle-mediated calcification. Effect of selective release of membrane-bound alkaline phosphatase and treatment with isosmotic pH 6 buffer. Journal of Biological Chemistry. 1986;261:9354. [PubMed]
19. Genge BR, Sauer GR, Wu LN, McLean FM, Wuthier RE. Correlation between loss of alkaline phosphatase activity and accumulation of calcium during matrix vesicle-mediated mineralization. Journal of Biological Chemistry. 1988;263:18513. [PubMed]
20. Boyan BD, Schwartz Z, Swain LD, Khare A. Role of lipids in calcification of cartilage. Anat Rec. 1989;224:211. [PubMed]
21. Ali SY. Constitutive enzymes of matrix vesicles. Bone and Mineral. 1992;17:168. [PubMed]
22. Chen D, Golub EE. Search for an endogenous collagenase in chicken endochondral bone matrix vesicles. Penn Dent J (Phila) 2001;101:12. [PubMed]
23. D'Angelo M, Billings PC, Pacifici M, Leboy PS, Kirsch T. Authentic matrix vesicles contain active metalloproteases (MMP). a role for matrix vesicle-associated MMP-13 in activation of transforming growth factor-beta. J Biol Chem. 2001;276:11347. [PubMed]
24. Dean DD, Schwartz Z, Muniz OE, Gomez R, Swain LD, Howell DS, Boyan BD. Matrix vesicles are enriched in metalloproteinases that degrade proteoglycans. Calcified Tissue International. 1992;50:342. [PubMed]
25. Wuthier RE, Wu LN, Sauer GR, Genge BR, Yoshimori T, Ishikawa Y. Mechanism of matrix vesicle calcification: characterization of ion channels and the nucleational core of growth plate vesicles. Bone and Mineral. 1992;17:290. [PubMed]
26. Kirsch T, Nah HD, Demuth DR, Harrison G, Golub EE, Adams SL, Pacifici M. Annexin V-mediated calcium flux across membranes is dependent on the lipid composition: implications for cartilage mineralization. Biochemistry. 1997;36:3359. [PubMed]
27. Xiao Z, Camalier CE, Nagashima K, Chan KC, Lucas DA, de la Cruz MJ, Gignac M, Lockett S, Issaq HJ, Veenstra TD, Conrads TP, Beck GR., Jr Analysis of the extracellular matrix vesicle proteome in mineralizing osteoblasts. J Cell Physiol. 2007;210:325. [PubMed]
28. Houston B, Stewart AJ, Farquharson C. PHOSPHO1--A novel phosphatase specifically expressed at sites of mineralisation in bone and cartilage. Bone. 2004;34:629. [PubMed]
29. Roberts S, Narisawa S, Harmey D, Mill+ín JL, Farquharson C. Functional Involvement of PHOSPHO1 in Matrix Vesicle-Mediated Skeletal Mineralization. Journal of Bone and Mineral Research. 2007;22:617. [PubMed]
30. Stewart AJ, Roberts SJ, Seawright E, Davey MG, Fleming RH, Farquharson C. The presence of PHOSPHO1 in matrix vesicles and its developmental expression prior to skeletal mineralization. Bone. 2006 [PubMed]
31. Robison R, Soames KH. The possible significance of hexophosphoric esters in ossification Part II. The Phosphoric Esterase of Ossifying Cartilage. Biochemical Journal. 1924;18:740. [PMC free article] [PubMed]
32. Fedde KN, Blair L, Silverstein J, Coburn SP, Ryan LM, Weinstein RS, Waymire K, Narisawa S, Millan JL, Macgregor GR, Whyte MP. Alkaline phosphatase knock-out mice recapitulate the metabolic and skeletal defects of infantile hypophosphatasia. Journal of Bone and Mineral Research. 1999;14:2015. [PMC free article] [PubMed]
33. Weiss MJ, Cole DE, Ray K, Whyte MP, Lafferty MA, Mulivor RA, Harris H. A missense mutation in the human liver/bone/kidney alkaline phosphatase gene causing a lethal form of hypophosphatasia. Proceedings of the National Academy of Sciences of the United States of America. 1988;85:7666. [PMC free article] [PubMed]
34. Whyte MP. Hypophosphatasia and the role of alkaline phosphatase in skeletal mineralization. Endocrine Reviews. 1994;15:439. Review. [PubMed]
35. Harmey D, Hessle L, Narisawa S, Johnson KA, Terkeltaub R, Millan JL. Concerted Regulation of Inorganic Pyrophosphate and Osteopontin by Akp2, Enpp1, and Ank: An Integrated Model of the Pathogenesis of Mineralization Disorders. Am J Pathol. 2004;164:1199. [PMC free article] [PubMed]
36. Hessle L, Johnson KA, Anderson HC, Narisawa S, Sali A, Goding JW, Terkeltaub R, Millan JL. Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proc Natl Acad Sci U S A. 2002;99:9445. [PMC free article] [PubMed]
37. Harrison G, Shapiro IM, Golub EE. The phosphatidylinositol- glycolipid anchor on alkaline phosphatase facilitates mineralization initiation in vitro. Journal of Bone and Mineral Research. 1995;10:568. [PubMed]
38. Anderson HC. Mineralization by matrix vesicles. Scan Electron Microsc. 1984:953. [PubMed]
39. Anderson HC. Matrix vesicles and calcification. Curr Rheumatol Rep. 2003;5:222. [PubMed]
40. Bonucci E. Comments on the ultrastructural morphology of the calcification process: an attempt to reconcile matrix vesicles, collagen fibrils, and crystal ghosts. Bone and Mineral. 1992;17:219. [PubMed]
41. Greenhill NS, Presland MR, Rogers KM, Stehbens WE. X-ray microanalysis of mineralized matrix vesicles of experimental saccular aneurysms. Experimental Molecular Pathology. 1985;43:220. [PubMed]
42. Wiesmann HP, Meyer U, Plate U, Hohling HJ. Aspects of collagen mineralization in hard tissue formation. Int Rev Cytol. 2005;242:121. [PubMed]
43. Genge BR, Cao X, Wu LN, Buzzi WR, Showman RW, Arsenault AL, Ishikawa Y, Wuthier RE. Establishment of the primary structure of the major lipid-dependent Ca2+ binding proteins of chicken growth plate cartilage matrix vesicles: identity with anchorin CII (annexin V) and annexin II. Journal of Bone and Mineral Research. 1992;7:807. [PubMed]
44. Kirsch T, Pfaffle M. Selective binding of anchorin CII (annexin V) to type II and X collagen and to chondrocalcin (C-propeptide of type II collagen). Implications for anchoring function between matrix vesicles and matrix proteins. FEBS Letters. 1992;310:143. [PubMed]
45. Kirsch T, Wuthier RE. Stimulation of calcification of growth-plate cartilage matrix vesicles by binding to type-II and type-X collagens. Journal of Biological Chemistry. 1994;269:11462. [PubMed]
46. Wu LN, Genge BR, Lloyd GC, Wuthier RE. Collagen-binding proteins in collagenase-released matrix vesicles from cartilage. Interaction between matrix vesicle proteins and different types of collagen. Journal of Biological Chemistry. 1991;266:1195. [PubMed]
47. Lucic D, Mollenhauer J, Kilpatrick KE, Cole AA. N-telopeptide of type II collagen interacts with annexin V on human chondrocytes. Connect Tissue Res. 2003;44:225. [PubMed]
48. Murshed M, Harmey D, Millan JL, McKee MD, Karsenty G. Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone. Genes Dev. 2005;19:1093. [PMC free article] [PubMed]
49. Wang W, Xu J, Du B, Kirsch T. Role of the Progressive Ankylosis Gene (ank) in Cartilage Mineralization. Mol Cell Biol. 2005;25:312. [PMC free article] [PubMed]
50. Garimella R, Bi X, Anderson HC, Camacho NP. Nature of phosphate substrate as a major determinant of mineral type formed in matrix vesicle-mediated in vitro mineralization: An FTIR imaging study. Bone. 2006;38:811. [PubMed]
51. Harmey D, Johnson KA, Zelken J, Camacho NP, Hoylaerts MF, Noda M, Terkeltaub R, Millan JL. Elevated skeletal osteopontin levels contribute to the hypophosphatasia phenotype in Akp2(-/-) mice. J Bone Miner Res. 2006;21:1377. [PubMed]
52. Addison WN, Azari F, Sorensen ES, Kaartinen MT, McKee MD. Pyrophosphate Inhibits Mineralization of Osteoblast Cultures by Binding to Mineral, Up-regulating Osteopontin, and Inhibiting Alkaline Phosphatase Activity. Journal of Biological Chemistry. 2007;282:15872. [PubMed]
53. Golub EE, Boesze-Battaglia K. The role of alkaline phosphatase in mineralization. Current Opinion in Orthopaedics. 2007;18:444.
54. Shapiro IM, Wuthier RE. A study of the phospholipids of bovine dental tissues II. Archives of Oral Biology. 1966;11:513. [PubMed]
55. Wuthier RE. Lipid composition of isolated epiphyseal cartilage cells, membranes and matrix vesicles. Biochim Biophys Acta. 1975;409:128. [PubMed]
56. Genge BR, Wu LN, Wuthier RE. Identification of phospholipid- dependent calcium-binding proteins as constituents of matrix vesicles. Journal of Biological Chemistry. 1989;264:10917. [PubMed]
57. Skrtic D, Eanes ED. Membrane-mediated precipitation of calcium phosphate in model liposomes with matrix vesicle-like lipid composition. Bone and Mineral. 1992;16:109. [PubMed]
58. Genge BR, Wu LNY, Wuthier RE. Kinetic analysis of mineral formation during in vitro modeling of matrix vesicle mineralization: Effect of annexin A5, phosphatidylserine, and type II collagen. Analytical Biochemistry. 2007;367:159. [PubMed]
59. Genge BR, Wu LNY, Wuthier RE. In Vitro Modeling of Matrix Vesicle Nucleation: Synergistic Stimulation of Mineral Formation by Annexin A5 and Phosphatidylserine. Journal of Biological Chemistry. 2007;282:26035. [PubMed]
60. Genge BR, Wu LNY, Wuthier RE. Mineralization of Annexin-5- containing Lipid-Calcium-Phosphate Complexes: Modulation by Varying Lipid Composition and Incubation with Cartilage Collagens. Journal of Biological Chemistry. 2008;283:9737. [PMC free article] [PubMed]
61. Genge BR, Wu LNY, Wuthier RE. Mineralization of biomimetic models of the matrix vesicle nucleation core: Effect of lipid composition and modulation by cartilage collagens. Journal of Biological Chemistry. 2008 M706523200.
62. Wu LNY, Genge BR, Wuthier RE. Analysis and Molecular Modeling of the Formation, Structure, and Activity of the Phosphatidylserine- Calcium-Phosphate Complex Associated with Biomineralization. Journal of Biological Chemistry. 2008;283:3827. [PubMed]
63. Leach RJ, Schwartz Z, Johnson-Pais TL, Dean DD, Luna M, Boyan BD. Osteosarcoma hybrids can preferentially target alkaline phosphatase activity to matrix vesicles: evidence for independent membrane biogenesis. Journal of Bone and Mineral Research. 1995;10:1614. [PubMed]
64. Damek-Poprawa M, Golub E, Otis L, Harrison G, Phillips C, Boesze-Battaglia K. Chondrocytes Utilize a Cholesterol Dependent Lipid Translocator to Externalize Phosphatidylserine. Biochemistry. 2006;45:3325. [PubMed]
65. Fedde KN. Human osteosarcoma cells spontaneously release matrix- vesicle-like structures with the capacity to mineralize. Bone and Mineral. 1992;17:145. [PubMed]
66. Gillette JM, Nielsen-Preiss SM. The role of annexin 2 in osteoblastic mineralization. Journal of Cell Science. 2004;117:441. [PubMed]
67. Thouverey C, Strzelecka-Kiliszek A, Balcerzak M, Buchet R, Pikula S. Matrix vesicles originate from apical membrane microvilli of mineralizing osteoblast-like Saos-2 cells. J Cell Biochem. 2009;106:127. [PubMed]
68. Ben Hur H, Ornoy A. Ultrastructural studies of initial stages of mineralization of long bones and vertebrae in human fetuses. Acta Anatomica (Basel) 1984;119:33. [PubMed]
69. Hale JE, Wuthier RE. The mechanism of matrix vesicle formation. Studies on the composition of chondrocyte microvilli and on the effects of microfilament-perturbing agents on cellular vesiculation. Journal of Biological Chemistry. 1987;262:1916. [PubMed]
70. Fisher LW, Fedarko NS. Six genes expressed in bones and teeth encode the current members of the SIBLING family of proteins. Connect Tissue Res. 2003;44 1:33. [PubMed]
71. Boskey AL, Maresca M, Ullrich W, Doty SB, Butler WT, Prince CW. Osteopontin-hydroxyapatite interactions in vitro: inhibition of hydroxyapatite formation and growth in a gelatin-gel. Bone and Mineral. 1993;22:147. [PubMed]
72. Boskey AL. Osteopontin and related phosphorylated sialoproteins - effects on mineralization. Annals of the New York Academy of Sciences. 1995;760:249. [PubMed]
73. Butler WT, Brunn JC, Qin C, Mckee MD. Extracellular matrix proteins and the dynamics of dentin formation. Connective Tissue Research. 2002;43:301. [PubMed]
74. He G, Dahl T, Veis A, George A. Nucleation of apatite crystals in vitro by self-assembled dentin matrix protein 1. Nat Mater. 2003;2:552. [PubMed]
75. He G, Dahl T, Veis A, George A. Dentin matrix protein 1 initiates hydroxyapatite formation in vitro. Connect Tissue Res. 2003;44 1:240. [PubMed]
76. Qin C, Baba O, Butler WT. Post-translational modifications of sibling proteins and their roles in osteogenesis and dentinogenesis. Crit Rev Oral Biol Med. 2004;15:126. [PubMed]
77. Tye CE, Rattray KR, Warner KJ, Gordon JA, Sodek J, Hunter GK, Goldberg HA. Delineation of the hydroxyapatite-nucleating domains of bone sialoprotein. Journal of Biological Chemistry. 2003;278:7949. [PubMed]
78. Kaartinen MT, Sun W, Kaipatur N, Mckee MD. Transglutaminase crosslinking of SIBLING proteins in teeth. J Dent Res. 2005;84:607. [PubMed]
79. Huang B, Sun Y, Maciejewska I, Qin D, Peng T, McIntyre B, Wygant J, Butler WT, Qin C. Distribution of SIBLING proteins in the organic and inorganic phases of rat dentin and bone. Eur J Oral Sci. 2008;116:104. [PMC free article] [PubMed]
80. Burton WN, Lust G, Macleod JN. Cartilage fibronectin isoforms: In search of functions for a special population of matrix glycoproteins. Matrix Biology. 1997;15:441. [PubMed]
81. Camper L, Heinegard D, Lundgren E. Integrin alpha-2-beta-1 is a receptor for the cartilage matrix protein chondroadherin. Journal of Cell Biology. 1997;138:1159. [PMC free article] [PubMed]
82. Johnson KA, Terkeltaub RA. External GTP-bound Transglutaminase 2 Is a Molecular Switch for Chondrocyte Hypertrophic Differentiation and Calcification. J Biol Chem. 2005;280:15004. [PubMed]
83. Lu Valle P, Iwamoto M, Fanning P, Pacifici M, Olsen BR. Multiple negative elements in a gene that codes for an extracellular matrix protein, collagen X, restrict expression to hypertrophic chondrocytes. J Cell Biol. 1993;121:1173. [PMC free article] [PubMed]
84. Pacifici M, Fellini SA, Holtzer H, De Luca S. Changes in the sulfated proteoglycans synthesized by “aging” chondrocytes. I. Dispersed cultured chondrocytes and in vivo cartilages. J Biol Chem. 1981;256:1029. [PubMed]
85. Wajih N, Borras T, Xue W, Hutson SM, Wallin R. Processing and Transport of Matrix {gamma}-Carboxyglutamic Acid Protein and Bone Morphogenetic Protein-2 in Cultured Human Vascular Smooth Muscle Cells: Evidence for an Uptake Mechanism for Serum Fetuin. J Biol Chem. 2004;279:43052. [PubMed]
86. Yasuda T, Shimizu K, Nakagawa Y, Ishikawa H, Nishihara H, Nakamura T. Possible involvement of RGD (Arg-Gly-Asp)-containing extracellular matrix proteins in rat growth plate chondrocyte differentiation in culture. Journal of Bone and Mineral Research. 1996;11:1430. [PubMed]
87. Jain A, Karadag A, Fohr B, Fisher LW, Fedarko NS. Three SIBLINGs (small integrin-binding ligand, N-linked glycoproteins) enhance factor H's cofactor activity enabling MCP-like cellular evasion of complement- mediated attack. J Biol Chem. 2002;277:13700. [PubMed]
88. Loeser RF. Modulation of integrin-mediated attachment of chondrocytes to extracellular matrix proteins by cations, retinoic acid, and transforming growth factor beta. Arthritis & Rheumatism. 1993;36(SUPPL):391A. [PubMed]
89. Veis A, Sfeir C, Wu CB. Phosphorylation of the proteins of the extracellular matrix of mineralized tissues by casein kinase-like activity. Crit Rev Oral Biol Med. 1997;8:360. [PubMed]
90. Katz EP, Wachtel E, Yamauchi M, Mechanic GL. The structure of mineralized collagen fibrils. Connective Tissue Research. 1989;21:149. [PubMed]
91. Landis WJ. An overview of vertebrate mineralization with emphasis on collagen-mineral interaction. Gravit Space Biol Bull. 1999;12:15. [PubMed]
92. Landis WJ, Hodgens KJ, Arena J, Song MJ, McEwen BF. Structural relations between collagen and mineral in bone as determined by high voltage electron microscopic tomography. Microsc Res Tech. 1996;33:192. [PubMed]
93. Tong W, Glimcher MJ, Katz JL, Kuhn L, Eppell SJ. Size and Shape of Mineralites in Young Bovine Bone Measured by Atomic Force Microscopy. Calcified Tissue International. 2003;72:592. [PubMed]
94. Fratzl P, Groschner M, Vogl G, Plenk H, Jr, Eschberger J, Fratzl- Zelman N, Koller K, Klaushofer K. Mineral crystals in calcified tissues: a comparative study by SAXS. Journal of Bone and Mineral Research. 1992;7:329. [PubMed]
95. Tesch W, Vandenbos T, Roschgr P, Fratzl-Zelman N, Klaushofer K, Beertsen W, Fratzl P. Orientation of mineral crystallites and mineral density during skeletal development in mice deficient in tissue nonspecific alkaline phosphatase. J Bone Miner Res. 2003;18:117. [PubMed]
96. Glimcher MJ. The nature of the mineral component of bone and the mechanism of calcification. Instructional Course Lectures. 1987;36:49. [PubMed]
97. Moradian-Oldak J, Frolow F, Addadi L, Weiner S. Interactions between acidic matrix macromolecules and calcium phosphate ester crystals: relevance to carbonate apatite formation in biomineralization. Proceedings of the Royal Society of London. Series B, Biological Sciences. 1992;247:47. [PubMed]
98. Posner AS, Blumenthal NC, Boskey AL. Formation and Transformation of Amorphous Calcium Phosphate to Hydroxyapatite, a Bone Analogue. In: Czitober M, editor. Calcified Tissue. Facta Publications; Vienna: 1973. pp. 1–4. Calcified Tissue.
99. Raggio CL, Boyan BD, Boskey AL. In vivo hydroxyapatite formation induced by lipids. J Bone Miner Res. 1986;1:409. [PubMed]
100. Shapiro IM, Golub EE, Kakuta S, Hazelgrove J, Havery J, Chance B, Frasca P. Initiation of endochondral calcification is related to changes in the redox state of hypertrophic chondrocytes. Science. 1982;217:950. [PubMed]
101. Wuthier RE. Involvement of cellular metabolism of calcium and phosphate in calcification of avian growth plate cartilage. Journal of Nutrition. 1993;123:301. [PubMed]
102. Glimcher MJ. On the Form and Function of Bone: From Molecules to Organs. Wolff's Law Revisited, 1981. In: Veis A, editor. The Chemistry and Biology of Mineralized Connective Tissues. Elsevier North Holland, Inc.; New York: 1981. pp. 617–673.
103. Boskey AL. Mineral-matrix interactions in bone and cartilage. Clinical Orthopaedics and Related Research. 1992;281:244. [PubMed]
104. Boyan BD, Schwartz Z, Swain LD. Matrix vesicles as a marker of endochondral ossification. Connective Tissue Research. 1990;24:67. [PubMed]
105. Wuthier RE. Mechanism of de novo mineral formation by matrix vesicles. Connective Tissue Research. 1989;22:27. [PubMed]
106. Boyan BD, Boskey AL. Co-isolation of proteolipids and calcium-phospholipid-phosphate complexes. Calcif Tissue Int. 1984;36:214. [PubMed]
107. He G, Ramachandran A, Dahl T, George S, Schultz D, Cookson D, Veis A, George A. Phosphorylation of Phosphophoryn Is Crucial for Its Function as a Mediator of Biomineralization. J Biol Chem. 2005;280:33109. doi: 10.1074/jbc.M500159200. [PubMed] [Cross Ref]
108. Hunter GK, Hauschka PV, Poole AR, Rosenberg LC, Goldberg HA. Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins. Biochemical Journal. 1996;317:59. [PMC free article] [PubMed]
109. Landis WJ, Hodgens KJ, Song MJ, Arena J, Kiyonaga S, Marko M, Owen C, McEwen BF. Mineralization of collagen may occur on fibril surfaces: evidence from conventional and high-voltage electron microscopy and three-dimensional imaging. J Struct Biol. 1996;117:24. [PubMed]
110. McEwen BF, Song MJ, Landis WJ. Quantitative determination of the mineral distribution in different collagen zones of calcifying tendon using high voltage electron microscopic tomography. J Comput Assist Microsc. 1991;3:201. [PubMed]
111. Boskey AL, Maresca M, Doty S, Sabsay B, Veis A. Concentration-dependent effects of dentin phosphophoryn in the regulation of in vitro hydroxyapatite formation and growth. Bone and Mineral. 1990;11:55. [PubMed]
112. He G, George A. Dentin Matrix Protein 1 Immobilized on Type I Collagen Fibrils Facilitates Apatite Deposition in Vitro. J Biol Chem. 2004;279:11649. [PubMed]
113. Hao J, Ramachandran A, George A. Temporal and Spatial Localization of the Dentin Matrix Proteins During Dentin Biomineralization. Journal of Histochemistry and Cytochemistry. 2008 jhc. [PMC free article] [PubMed]
114. Toroian D, Price PA. The essential role of fetuin in the serum-induced calcification of collagen. Calcif Tissue Int. 2008;82:116. [PubMed]
115. Gorski JP, Huffman NT, Cui C, Henderson EP, Midura RJ, Seidah NG. Potential role of proprotein convertase SKI-1 in the mineralization of primary bone. Cells Tissues Organs. 2009;189:25. [PMC free article] [PubMed]
116. Anderson HC, Sipe JB, Hessle L, Dhamyamraju R, Atti E, Camacho NP, Millan JL. Impaired Calcification Around Matrix Vesicles of Growth Plate and Bone in Alkaline Phosphatase-Deficient Mice. Am J Pathol. 2004;164:841. [PMC free article] [PubMed]
117. Arispe N, Rojas E, Genge BR, Wu LN, Wuthier RE. Similarity in calcium channel activity of annexin V and matrix vesicles in planar lipid bilayers. Biophysical Journal. 1996;71:1764. [PMC free article] [PubMed]
118. Nielsen LB, Pedersen FS, Pedersen L. Expression of type III sodium-dependent phosphate transporters/retroviral receptors mRNAs during osteoblast differentiation. Bone. 2001;28:160. [PubMed]
119. Wu LN, Sauer GR, Genge BR, Valhmu WB, Wuthier RE. Effects of analogues of inorganic phosphate and sodium ion on mineralization of matrix vesicles isolated from growth plate cartilage of normal rapidly growing chickens. J Inorg Biochem. 2003;94:221. [PubMed]
120. Anderson HC, Garimella R, Tague SE. The role of matrix vesicles in growth plate development and biomineralization. Front Biosci. 2005;10:822. [PubMed]
121. Kirsch T, Ishikawa Y, Mwale F, Wuthier RE. Roles of the nucleational core complex and collagens (types II and X) in calcification of growth plate cartilage matrix vesicles. J Biol Chem. 1994;269:20103. [PubMed]
122. Wu LN, Genge BR, Sauer GR, Wuthier RE. Characterization and reconstitution of the nucleational complex responsible for mineral formation by growth plate cartilage matrix vesicles. Connective Tissue Research. 1996;35:309. [PubMed]
123. Beertsen W, Holmbeck K, Niehof A, Bianco P, Chrysovergis K, Birkedal-Hansen H, Everts V. On the role of MT1-MMP, a matrix metalloproteinase essential to collagen remodeling, in murine molar eruption and root growth. Eur J Oral Sci. 2002;110:445. [PubMed]
124. Bourd-Boittin K, Septier D, Hall R, Goldberg M, Menashi S. Immunolocalization of Enamelysin (Matrix Metalloproteinase-20) in the Forming Rat Incisor. J Histochem Cytochem. 2004;52:437. [PubMed]
125. Inada M, Wang Y, Byrne MH, Rahman MU, Miyaura C, Lopez-Otin C, Krane SM. Critical roles for collagenase-3 (Mmp13) in development of growth plate cartilage and in endochondral ossification. PNAS. 2004 0407788101. [PMC free article] [PubMed]
126. Leff RL, Elias I, Ionescu M, Reiner A, Poole AR. Molecular changes in human osteoarthritic cartilage after 3 weeks of oral administration of BAY 12-9566, a matrix metalloproteinase inhibitor. J Rheumatol. 2003;30:544. [PubMed]
127. Mwale F, Tchetina E, Wu CW, Poole AR. The assembly and remodeling of the extracellular matrix in the growth plate in relationship to mineral deposition and cellular hypertrophy: an in situ study of collagens II and IX and proteoglycan. Journal of Bone and Mineral Research. 2002;17:275. [PubMed]
128. Poole AR, Nelson F, Dahlberg L, Tchetina E, Kobayashi M, Yasuda T, Laverty S, Squires G, Kojima T, Wu W, Billinghurst RC. Proteolysis of the collagen fibril in osteoarthritis. Biochem Soc Symp. 2003:115. [PubMed]
129. Wu CW, Tchetina EV, Mwale F, Hasty K, Pidoux I, Reiner A, Chen J, Van Wart HE, Poole AR. Proteolysis involving matrix metalloproteinase 13 (collagenase-3) is required for chondrocyte differentiation that is associated with matrix mineralization. J Bone Miner Res. 2002;17:639. [PubMed]
130. Manduca P, Castagnino A, Lombardini D, Marchisio S, Soldano S, Ulivi V, Zanotti S, Garbi C, Ferrari N, Palmieri D. Role of MT1-MMP in the osteogenic differentiation. Bone. 2009;44:251. [PubMed]
131. Mosig RA, Dowling O, DiFeo A, Ramirez MC, Parker IC, Abe E, Diouri J, Aqeel AA, Wylie JD, Oblander SA, Madri J, Bianco P, Apte SS, Zaidi M, Doty SB, Majeska RJ, Schaffler MB, Martignetti JA. Loss of MMP-2 disrupts skeletal and craniofacial development and results in decreased bone mineralization, joint erosion and defects in osteoblast and osteoclast growth. Hum Mol Genet. 2007;16:1113. [PMC free article] [PubMed]
132. Blair HC, Dean DD, Howell DS, Teitelbaum SL, Jeffrey JJ. Hypertrophic chondrocytes produce immunoreactive collagenase in vivo. Connective Tissue Research. 1989;23:65. [PubMed]
133. Dean DD, Muniz OE, Woessner JF, Jr, Howell DS. Production of collagenase and tissue inhibitor of metalloproteinases (TIMP) by rat growth plates in culture. Matrix. 1990;10:320. [PubMed]
134. Katsura N, Yamada K. Isolation and characterization of a metalloprotease associated with chicken epiphyseal cartilage matrix vesicles. Bone. 1986;7:137. [PubMed]
135. Vu TH, Shipley JM, Bergers G, Berger JE, Helms JA, Hanahan D, Shapiro SD, Senior RM, Werb Z. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell. 1998;93:411. [PMC free article] [PubMed]
136. Behrendtsen O, Werb Z. Metalloproteinases regulate parietal endoderm differentiating and migrating in cultured mouse embryos. Dev Dyn. 1997;208:255. [PubMed]
137. Chin JR, Werb Z. Matrix metalloproteinases regulate morphogenesis, migration and remodeling of epithelium, tongue skeletal muscle and cartilage in the mandibular arch. Development. 1997;124:1519. [PubMed]
138. Iamaroon A, Wallon UM, Overall CM, Diewert VM. Expression of 72-kDa gelatinase (matrix metalloproteinase-2) in the developing mouse craniofacial complex. Archives of Oral Biology. 1996;41:1109. [PubMed]
139. Tanney DC, Feng L, Pollock AS, Lovett DH. Regulated expression of matrix metalloproteinases and TIMP in nephrogenesis. Dev Dyn. 1998;213:121. [PubMed]
140. Werb Z, Chin JR. Extracellular matrix remodeling during morphogenesis. Ann N Y Acad Sci. 1998;857:110. [PubMed]
141. Dolo V, Ginestra A, Cassara D, Violini S, Lucania G, Torrisi MR, Nagase H, Canevari S, Pavan A, Vittorelli ML. Selective localization of matrix metalloproteinase 9, beta1 integrins, and human lymphocyte antigen class I molecules on membrane vesicles shed by 8701-BC breast carcinoma cells. Cancer Research. 1998;58:4468. [PubMed]
142. Ginestra A, Monea S, Seghezzi G, Dolo V, Nagase H, Mignatti P, Vittorelli ML. Urokinase plasminogen activator and gelatinases are associated with membrane vesicles shed by human HT1080 fibrosarcoma cells. Journal of Biological Chemistry. 1997;272:17216. [PubMed]
143. Ginestra A, La Placa MD, Saladino F, Cassara D, Nagase H, Vittorelli ML. The amount and proteolytic content of vesicles shed by human cancer cell lines correlates with their in vitro invasiveness. Anticancer Res. 1998;18:3433. [PubMed]
144. Brown RA, Kayser M, McLaughlin B, Weiss JB. Collagenase and gelatinase production by calcifying growth plate chondrocytes. Experimental Cell Research. 1993;208:1. [PubMed]
145. Dean DD, Schwartz Z, Bonewald L, Muniz OE, Morales S, Gomez R, Brooks BP, Qiao M, Howell DS, Boyan BD. Matrix vesicles produced by osteoblast-like cells in culture become significantly enriched in proteoglycan-degrading metalloproteinases after addition of beta- glycerophosphate and ascorbic acid. Calcified Tissue International. 1994;54:399. [PubMed]
146. Moradian-Oldak J, Simmer JP, Sarte PE, Zeichner-David M, Fincham AG. Specific cleavage of a recombinant murine amelogenin at the carboxy-terminal region by a proteinase fraction isolated from developing bovine tooth enamel. Archives of Oral Biology. 1994;39:647. [PubMed]
147. Boskey AL, Boyan BD, Doty SB, Feliciano A, Greer K, Weiland D, Swain LD, Schwartz Z. Studies of matrix vesicle-induced mineralization in a gelatin gel. Bone Miner. 1992;17:257. [PubMed]
148. Boskey AL, Boyan BD, Schwartz Z. Matrix vesicles promote mineralization in a gelatin gel. Calcif Tissue Int. 1997;60:309. [PubMed]
149. Maeda S, Dean DD, Sylvia VL, Boyan BD, Schwartz Z. Metalloproteinase activity in growth plate chondrocyte cultures is regulated by 1,25-(OH)(2)D(3) and 24,25-(OH)(2)D(3) and mediated through protein kinase C. Matrix Biol. 2001;20:87. [PubMed]
150. Schmitz JP, Schwartz Z, Sylvia VL, Dean DD, Calderon F, Boyan BD. Vitamin D3 regulation of stromelysin-1 (MMP-3) in chondrocyte cultures is mediated by protein kinase C. Journal of Cell Physiology. 1996;168:570. [PubMed]
151. Arner EC, Tortorella MD. Signal transduction through chondrocyte integrin receptors induces matrix metalloproteinase synthesis and synergizes with interleukin-1. Arthritis & Rheumatism. 1995;38:1304. [PubMed]
152. Cawston T, Billington C, Cleaver C, Elliott S, Hui W, Koshy P, Shingleton B, Rowan A. The regulation of MMPs and TIMPs in cartilage turnover. Ann N Y Acad Sci. 1999;878:120. [PubMed]
153. Dean DD, Boyan BD, Muniz OE, Howell DS, Schwartz Z. Vitamin D metabolites regulate matrix vesicle metalloproteinase content in a cell maturation-dependent manner. Calcified Tissue International. 1996;59:109. [PubMed]
154. Hirsch MS, Moses MA, Svoboda KKH. Integrin subunit antibodies (beta-1, alpha-2 and alpha-3) inhibit type X collagen secretion and increase metalloproteinase inhibitor expression in serum free cartilage organ cultures. Molecular Biology of the Cell. 1995;6(SUPPL):391A.
155. Jimenez MJ, Balbin M, Lopez JM, Alvarez J, Komori T, Lopez-Otin C. Collagenase 3 is a target of Cbfa1, a transcription factor of the runt gene family involved in bone formation. Mol Cell Biol. 1999;19:4431. [PMC free article] [PubMed]
156. Boyan BD, Schwartz Z. 1,25-Dihydroxy vitamin D3 is an autocrine regulator of extracellular matrix turnover and growth factor release via ERp60-activated matrix vesicle matrix metalloproteinases. Cells Tissues Organs. 2009;189:70. [PMC free article] [PubMed]
157. Gross J. An Essay on Biological Degradation of Collagen. In: Hay ED, editor. Cell biology of the extracellular matrix. Plenum; New York: 1981. pp. 217–258.
158. Krane SM, Byrne MH, Lemaitre V, Henriet P, Jeffrey JJ, Witter JP, Liu X, Wu H, Jaenisch R, Eeckhout Y. Different Collagenase Gene Products Have Different Roles in Degradation of Type I Collagen. J Biol Chem. 1996;271:28509. doi: 10.1074/jbc.271.45.28509. [PubMed] [Cross Ref]
159. Croucher LJ, Hollander AP. Differential detection of type II collagen N-terminal and C-terminal denaturation epitopes in degrading cartilage. Mol Pathol. 1999;52:323. [PMC free article] [PubMed]
160. Brachvogel B, Dikschas J, Moch H, Welzel H, von der MK, Hofmann C, Poschl E. Annexin A5 is not essential for skeletal development. Mol Cell Biol. 2003;23:2907. [PMC free article] [PubMed]
161. Balcerzak M, Malinowska A, Thouverey C, Sekrecka A, Dadlez M, Buchet R, Pikula S. Proteome analysis of matrix vesicles isolated from femurs of chicken embryo. Proteomics. 2008;8:192. [PubMed]
162. Xiao Z, Camalier CE, Nagashima K, Chan KC, Lucas DA, de la Cruz MJ, Gignac M, Lockett S, Issaq HJ, Veenstra TD, Conrads TP, Beck GR., Jr Analysis of the Extracellular Matrix Vesicle Proteome in Mineralizing Osteoblasts. Journal of Bone and Mineral Research. 2006;21:S127. [PubMed]
163. Xiao Z, Conrads TP, Beck GR, Veenstra TD. Analysis of the extracellular matrix and secreted vesicle proteomes by mass spectrometry. Methods Mol Biol. 2008;428:231. [PubMed]
164. Xiao Z, Blonder J, Zhou M, Veenstra TD. Proteomic analysis of extracellular matrix and vesicles. J Proteomics. 2009;72:34. [PubMed]
PubReader format: click here to try

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...